Last Updated: June 25, 2026

Suppliers and packagers for lanorinal


✉ Email this page to a colleague

« Back to Dashboard


lanorinal

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sandoz LANORINAL aspirin; butalbital; caffeine CAPSULE;ORAL 086996 ANDA Lannett Company, Inc. 0527-1552-01 100 CAPSULE in 1 BOTTLE (0527-1552-01) 1985-10-11
Sandoz LANORINAL aspirin; butalbital; caffeine CAPSULE;ORAL 086996 ANDA Sandoz Inc 0781-2270-01 100 CAPSULE in 1 BOTTLE (0781-2270-01) 2024-09-03
Sandoz LANORINAL aspirin; butalbital; caffeine CAPSULE;ORAL 086996 ANDA Chartwell RX, LLC 62135-433-90 90 CAPSULE in 1 BOTTLE (62135-433-90) 1985-10-11
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

LANORINAL Suppliers: Active Pharmaceutical Ingredient, Contract Manufacturers, and Key Upstream Vendors

Last updated: June 2, 2026

Which companies supply LANORINAL’s active ingredient and key intermediates?

No sufficient, verifiable public information is available in the provided context to identify LANORINAL’s active pharmaceutical ingredient (API), its chemical identity, or upstream intermediate suppliers. Without the API and manufacturing details, any supplier list would be speculative.

What contract manufacturing organizations (CMOs) produce LANORINAL?

No verifiable, sourceable details are provided that link LANORINAL to specific CMOs, drug product sites, or marketing authorization holder manufacturing locations. A supplier mapping requires confirmed manufacturing ownership or labeling/accountability data.

Who are the upstream API suppliers for LANORINAL?

No confirmed API identity, dossier reference, or supplier/DMF linkage is available, preventing identification of API manufacturers, intermediate suppliers, or agents associated with LANORINAL production.

What evidence identifies LANORINAL suppliers (Orange Book, DMF, labels, or inspections)?

No dossier, FDA/EMA review, Orange Book listing, inspection database hits, or manufacturer-of-record documentation is included here for LANORINAL. Without those records, supplier identification cannot be performed accurately.

Does LANORINAL have multiple formulation sites or regional manufacturers?

No regulatory or product-label manufacturing-site information is available in the provided context, so multi-site or region-specific supply cannot be determined.

Which distributors supply LANORINAL to pharmacies and hospitals?

No distribution-channel data, wholesaler listings, or tender/health-system procurement records are provided for LANORINAL.

Key Takeaways

  • LANORINAL supplier mapping (API, intermediates, CMOs, and distributors) cannot be produced from the provided information.
  • Accurate supplier identification requires a confirmed API and manufacturing-accountability records (e.g., FDA/EMA dossiers, labels, or inspection identifiers), none of which are present in the request context.
  • Any supplier list would be speculative and not actionable for licensing, regulatory, or litigation decisions.

FAQs

  1. What is LANORINAL’s active ingredient (API)?
    Not provided in the request context.

  2. Is LANORINAL an FDA-approved product with an Orange Book listing?
    No listing information is provided.

  3. Are LANORINAL labels identifying a manufacturer-of-record or packager?
    No label data is provided.

  4. Does LANORINAL rely on DMF-referenced API supply?
    DMF linkage information is not provided.

  5. Can LANORINAL be manufactured by multiple CMOs across regions?
    No site or region manufacturing data is provided.

References

No sources were provided or cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.